ArticleJournal of the Society for Cardiovascular Angiography & Interventions2026
Comparison of Outcomes in Patients With and Without Chronic Kidney Disease Undergoing Transcatheter Tricuspid Valve Replacement.
Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with chronic kidney disease (CKD), including end-stage renal disease (ESRD), undergoing transcatheter tricuspid valve replacement (TTVR) may be at increased risk of adverse outcomes. We compared clinical outcomes after TTVR in patients with versus without CKD/ESRD. Methods: We analyzed 145 patients who underwent TTVR for tricuspid regurgitation (TR). Patients were stratified into 2 cohorts: CKD/ESRD (dialysis dependence and/or estimated glomerular filtration rate <30 mL/min/1.73 m Results: Patients with CKD/ESRD were slightly younger (76.3 years [IQR, 69.2-78.6] vs 80.8 years [IQR, 73.4-85.0]; Conclusions: TTVR in patients with CKD/ESRD provides comparable functional improvement to that in patients without CKD. However, the patients with CKD/ESRD group have a significantly higher rate of pacemaker implantation, highlighting the need for individualized risk assessment and careful clinical management in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.